Featured Book


Accentia Biopharma Misses $14.1-Mil. Debenture Payment

Thursday, 29 November 2012 23:03
Rate this item
(0 votes)

Accentia Biopharmaceuticals, Inc., failed to pay an aggregate of $14.1 million in principal amount that became due on Nov. 17, 2012, under a class of non-interest bearing convertible debentures issued in November 2010.

Please log in or register to view the entire article

Login to post comments

Featured News

  • Takata Corp. et al. Proposes to Pay $47.4 Million to Key Vendors

    TK Holdings Inc. and other Takata Corp. units that have sought Chapter 11 protection are seeking approval from the U.S. Bankruptcy Court for the District of Delaware to pay $47.4 million of the $118 million owed to various third-party providers of goods and services.

    The Debtors are only seeking approval to pay the prepetition claims of "critical vendors", i.e. vendors, suppliers, service providers, and other similar parties and entities that are essential to maintaining the going concern value of the Debtors' businesses.

    Written on Tuesday, 27 June 2017 02:03 in Latest News Be the first to comment! Read 10 times Read more...